CISS | TOAST | Total |
|---|
LAA | CE | SAO | SOE | SUE |
|---|
LAA | 78 | 3 | 30 | 0 | 38 | 149 |
LAA-A | 0 | 0 | 0 | 0 | 0 | 0 |
LAA-1 | 37 | 0 | 24 | 0 | 8 | 69 |
LAA-2 | 20 | 2 | 4 | 0 | 15 | 41 |
LAA-3 | 4 | 0 | 0 | 0 | 5 | 9 |
LAA-4 | 17 | 3 | 2 | 0 | 10 | 30 |
CS | 0 | 10 | 1 | 0 | 2 | 13 |
PAD | 9 | 1 | 96 | 1 | 25 | 132 |
OE | 0 | 0 | 0 | 6 | 0 | 6 |
UE | 2 | 1 | 0 | 0 | 17 | 20 |
Total | 89 | 15 | 127 | 7 | 82 | 320 |
-
CISS Chinese ischemic stroke subclassfication, TOAST trial of Org 10172 in acute stroke treatment, LAA large artery atherosclerosis, LAA-A aortic arch atherosclerosis, LAA-1 parent artery (plaque or thrombus) occluding penetrating artery, LAA-2 artery-to-artery embolism, LAA-3 hypoperfusion/impaired emboli clearance, LAA-4 hypoperfusion/impaired emboli clearance, CS cardiogenic stroke, PAD penetrating artery disease, OE other etiologies, UE undetermined etiology, CE cardioembolism, SAO small-artery occlusion, SOE stroke of other etiologies, SUE stroke of undetermined etiology
-
k = 0.487
